why choose us

First received: March 13, 2023

Clinical Trial: Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Follicular Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Study of Glofitamab and Obinutuzumab for First-line Treatment of Follicular Lymphoma and Marginal Zone Lymphoma

Brief Summary: The purpose of this study is to determine how effective and safe the combination of glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not received other treatments for their lymphoma.The names of the study drugs involved in this study are:Glofitamab (a type of immunotherapy)Obinutuzumab (a type of immunotherapy)

Read more